Critical Metals Corp (CRML) Skyrockets on U.S. Stake Rumors – Inside the Tanbreez Rare Earth Power Play

Critical Metals (CRML) Stock Explodes on Rare-Earth Boom – Gains Skyrocket Amid U.S. Investment Buzz

  • U.S. stake rumor sparks rally: CRML shares jumped ~62% on Oct.6 after Reuters reported the U.S. government was “in talks to buy a stake” in the company’s Greenland rare-earth project [1]. Benchmark Mineral Intelligence notes that a U.S. stake in Tanbreez would be “a significant step toward building a diversified ‘mine-to-magnet’ supply chain independent of China” [2].
  • Major deals boost confidence: On Oct.6 CRML closed a $35 million private-placement financing (PIPE) to fund Tanbreez development [3]. Two days later it announced a 10-year letter of intent to supply 15% of Tanbreez output to U.S. processor REalloys [4] [5], lifting the stock ~21%. These offtakes (with REalloys and earlier Ucore deals) now cover ~25% of production.
  • Wild price swings: CRML hit new 52-week highs (~$32 intraday) in mid-Oct [6] before collapsing ~24% on Oct.15 to $22.72 [7]. The stock rebounded to about $24 by Oct.16 morning [8]. MarketBeat notes CRML is trading far above its historical range (the 50-day avg was just ~$7.62) and has seen record volatility (±35% intraday swings) [9] [10].
  • Mixed analyst views: Ratings are split – Weiss Ratings reiterated a sell warning (saying current levels assume “perfect execution” on all projects) [11], and Wall Street Zen cut CRML from “Hold” to Sell [12]. By contrast, one research service lists a lone “Strong Buy” and a 12-month target of $12 (implying ~50% downside) [13].
  • Demand-driven sector: The rally reflects a booming critical-minerals market. By 2024 global lithium demand rose ~30% (versus 10% annual in prior years) and rare-earth demand +6–8% [14], driven by EVs, renewables and defense. U.S. and EU policy is aggressively shifting supply chains: on Oct.15 U.S. Trade Rep. Greer blasted China’s proposed rare-earth export curbs as a “global supply-chain power grab” [15], underscoring why Western miners like CRML are in favor. Peers also rallied – for example, MP Materials jumped ~19% on Oct.13 after the U.S. Pentagon funded its U.S. rare-earth plant [16].
  • Trading frenzy: Retail interest has surged CRML’s volume. More than 60 million shares traded on Oct.14 alone (per Benzinga Pro data) [17], making it a “meme”-like roller-coaster. JPMorgan’s Oct.13 announcement of a $1.5 trillion investment initiative (with “critical minerals” first on the list) helped fuel the mania – CEO Jamie Dimon said “America needs more speed and investment” [18], adding momentum to stocks like CRML.

Stock Price and Recent Performance

As of Oct.16, 2025 midday, CRML trades in the mid-$20s, rebounding from Oct.15’s close at $22.72 [19]. That day’s 24% plunge followed a parabolic run higher: in early Oct the stock was only single digits, yet by Oct.13 it hit a 52-week high ($21.45 intraday) and by Oct.14 briefly traded near $32 [20]. These gains made CRML one of the top Nasdaq performers. On Oct.6 alone the stock spiked over 60%, reflecting Reuters’s scoop on a possible U.S. equity investment [21] [22]. Volume has been enormous – Oct.15 saw ~51 million shares traded ($1.16 billion value) [23] – and volatility remains very high (StockInvest labels CRML “very high risk” given daily swings over 30% [24]).

Technically, CRML broke well above long-term resistance in the $19–20 range during this rally [25]. Short-term moving averages are surging, prompting some buy signals [26]. However, chart analysts warn that near-term support now lies around $17 [27], so a break below could see steep losses. Given the stock’s extreme run-up, many traders are taking profits or setting tight stop-loss orders to manage risk.

Recent News and Catalysts

Several recent developments drove CRML’s surge: First, government backing – Reuters confirmed CRML’s application for a $50 M U.S. Defense Production Act grant could be converted into roughly an 8% equity stake [28] [29]. The White House later cautioned nothing was decided, but the rumor alone triggered the Oct.6 rally. Analysts call the prospect strategically huge: a stake in Tanbreez “would mark a significant step” toward a Western rare-earth supply chain independent of China [30].

Second, financing – on Oct.6 CRML announced it had raised $35 M from a new institutional investor, issuing 5 million shares (plus warrants) to advance Tanbreez [31]. CEO Tony Sage said this “validates the opportunities ahead for Tanbreez” and underscores rising Western demand for heavy REEs [32].

Third, offtake partnerships – on Oct.8 the company signed a 10-year letter of intent with REalloys Inc. to take up to 15% of Tanbreez’s output for U.S. magnet-making [33] [34]. Combined with an earlier August deal with Ucore (10 ktpa for 10 years), roughly 25% of Tanbreez production is now earmarked for U.S. processors [35] [36]. Each announcement sent the stock higher (REalloys news alone spiked CRML ~21% [37]). REalloys CEO Lipi Mainheim hailed Tanbreez as “a remarkable opportunity… vital to the defense industrial base” [38], highlighting its strategic value.

Finally, Greenland positioning – in late Sept CRML agreed to increase its Tanbreez stake from 42% to 92.5% (pending government approval) [39], making it the controlling partner in this massive deposit. Drilling has confirmed roughly 4.7 billion tonnes of ore rich in heavy rare earth oxides [40] (dysprosium and terbium, which are crucial for EVs, wind turbines and defense tech). Analysts note Tanbreez is “a massive high-grade rare-earth deposit” with heavy-REE content [41] – a potential game-changer for U.S. supply. On the lithium side, CRML’s Wolfsberg project in Austria is fully permitted and positioned for Europe’s electric-vehicle battery boom [42].

These developments have put CRML in the center of Washington’s critical-minerals push. U.S. agencies (EXIM Bank, DoD) have extended letters of interest or grants to the project, and even the EU is exploring Greenland partnerships [43]. For context, the U.S. has been taking equity stakes in peers like MP Materials and Lithium Americas as part of this strategy [44] [45].

Valuation and Analyst Forecasts

Despite the buzz, CRML’s fundamentals remain lean. For 2025 the company reported only ~$0.56 million in revenue (up from $117k) [46] against a net loss of $51.9 million. In other words, it’s essentially an explorer with virtually no sales yet. With a market cap around $2.4 billion, that implies an EV-to-sales ratio well over 1,000× [47]. One analyst points out CRML trades at ~$1.6B enterprise value on only ~$0.5M in sales [48] – astonishing by any measure. As Weiss Ratings cautions, the current stock price assumes “perfect execution” of all these projects [49].

Against this backdrop, formal forecasts are modest. StockAnalysis.com shows a lone analyst issuing a Strong Buy but with a 12-month target of just $12 [50] – about 47% below current levels. (Any upside may come from accelerating project milestones or a formal U.S. investment.) In fact, one quantitative model (StockInvest) projects a ~54% further gain in the next three months – giving a wide 90% confidence range of roughly $12–$46 [51]. This reflects the stock’s wild swings: recent support levels ($17 and $9) and short-term targets ($22+) are speculative.

Technically, analysts note CRML’s momentum is extremely strong but precarious. Both 50-day and 200-day moving averages (around ~$6–7 before October) have been blasted through [52]. Some chart watchers now see near-term resistance above ~$22 and support nearer $17 [53]. Trading strategists advise caution: Tim Bohen (StocksToTrade) urges investors to have a “clear entry strategy” and not blindly chase this rally [54]. Indeed, many suggest taking partial profits after such gains.

On balance, major firms have become mixed or bearish. MarketBeat notes Weiss Ratings and Wall Street Zen each issued sell calls on CRML this week [55]. No major bank has upgraded CRML with a high target – even bullish outlets cap 12-month forecasts near the pre-rally price (around $12–$15) [56]. In short, fundamentals lag behind the hype, so risk management is vital.

Critical Minerals Market and Peers

CRML’s surge is part of a broader commodities theme. Western governments and industries are frantically securing alternatives to China’s grip on critical minerals. China still dominates ~85–90% of rare-earth processing and about 60% of mining [57]. U.S. and EU leaders have invoked emergency powers (like the Defense Production Act) and funding to break this dominance. The IEA reports that in 2024 lithium demand jumped ~30% (far above its long-term 10% rate) and rare-earth demand rose ~6–8%, driven by EVs, batteries and grid tech [58]. This underpins the strategic rush.

In this environment, other miners are also rallying. For example, MP Materials (NYSE: MP) surged ~13% on Oct.13 (19% intraday) after the U.S. Pentagon invested $400 M in its Idaho rare-earth plant [59]. Lynas Rare Earths (ASX:LYC) and other European lithium explorers have similarly seen gains as news of supply risks spread. Notably, on Oct.13–15 China provoked markets by expanding rare-earth export controls. U.S. officials immediately blasted the move – calling it a “power grab” – and even floated tariff retaliation [60]. Such headlines send investors toward U.S.-listed miners.

CRML sits at the intersection of these trends: it offers exposure to both rare earths (heavy REEs for magnets) and lithium (for EV batteries). Its Greenland Tanbreez deposit is unique in having high-grade dysprosium and terbium (heavy REEs crucial for EV motors and defense) [61]. REalloys’ deal highlights that content, and the U.S. sees this asset as “vital to the defense industrial base” [62]. Meanwhile, Wolfsberg could tap the booming EU battery market. Investors compare CRML’s situation to a high-stakes bet on geopolitics as much as geology.

Outlook – Cautious Optimism

With critical-mineral policies accelerating, CRML’s story is compelling – but execution hurdles remain. The stock’s ride is driven by expectation of massive future value. If the U.S. indeed formalizes funding or partnerships, and Tanbreez development stays on track, analysts see upside. As one analyst put it, JPMorgan’s pledge of “America needs more speed and investment” into critical industries [63] could speed that path. But if any element fails (e.g. Greenland approvals stall or China’s trade war cools), the stock could retreat sharply.

In the near term (Oct.16 onward), the focus is on follow-through: Does Washington officially invest? Do trading levels hold above key technical supports? Many market watchers emphasize risk control. Given the 10x+ volatility CRML has shown, experienced investors plan for swings. Some suggest locking in profits earned so far and waiting for clearer catalysts. As sentiment shifts quickly, having a plan is crucial.

Bottom Line: Critical Metals Corp epitomizes a high-risk, high-reward play on U.S. rare-earth strategy. Its stock has exploded on government and offtake news, but it’s far from a sure thing. Experts agree the fundamentals are still minimal and the valuation is aggressive [64] [65]. Yet if CRML can deliver on Tanbreez and lithium milestones, the strategic upside is enormous. For now, investors are watching developments daily – any sign of real government backing or resource breakthroughs could send CRML higher, while setbacks could trigger steep sell-offs.

Sources: Reuters, TechStock², MarketBeat, StockInvest, Benzinga, IEA and company filings [66] [67] [68] [69] [70] [71], among others. Each source is cited in context above.

Top 5 Rare Earth & Critical Mineral Stocks to Watch in September 2025

References

1. www.reuters.com, 2. www.reuters.com, 3. ts2.tech, 4. www.reuters.com, 5. ts2.tech, 6. ts2.tech, 7. www.marketbeat.com, 8. stockanalysis.com, 9. stockinvest.us, 10. www.marketbeat.com, 11. ts2.tech, 12. www.marketbeat.com, 13. stockanalysis.com, 14. www.iea.org, 15. www.reuters.com, 16. stockstotrade.com, 17. www.benzinga.com, 18. www.benzinga.com, 19. www.marketbeat.com, 20. ts2.tech, 21. www.reuters.com, 22. ts2.tech, 23. stockinvest.us, 24. stockinvest.us, 25. stockanalysis.com, 26. stockinvest.us, 27. ts2.tech, 28. www.reuters.com, 29. www.reuters.com, 30. www.reuters.com, 31. ts2.tech, 32. ts2.tech, 33. www.reuters.com, 34. ts2.tech, 35. www.reuters.com, 36. ts2.tech, 37. www.reuters.com, 38. ts2.tech, 39. ts2.tech, 40. ts2.tech, 41. ts2.tech, 42. ts2.tech, 43. ts2.tech, 44. www.reuters.com, 45. ts2.tech, 46. stockanalysis.com, 47. ts2.tech, 48. ts2.tech, 49. ts2.tech, 50. stockanalysis.com, 51. stockinvest.us, 52. ts2.tech, 53. ts2.tech, 54. ts2.tech, 55. www.marketbeat.com, 56. stockanalysis.com, 57. ts2.tech, 58. www.iea.org, 59. stockstotrade.com, 60. www.reuters.com, 61. ts2.tech, 62. ts2.tech, 63. www.benzinga.com, 64. ts2.tech, 65. www.marketbeat.com, 66. www.reuters.com, 67. ts2.tech, 68. www.reuters.com, 69. www.marketbeat.com, 70. stockanalysis.com, 71. www.reuters.com

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?
Previous Story

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next
Next Story

Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Stock Market Today

  • Veeva Systems Leads AI-Driven Drug Discovery in Healthcare - Is It a Buy?
    October 16, 2025, 9:52 AM EDT. Veeva Systems (NYSE: VEEV) stands at the intersection of AI and healthcare, selling a dominant suite of industry-cloud software for biopharma that generates recurring, sticky revenue. The firm has built out data-rich platforms linking regulatory, clinical, and commercial data, positioning it to monetize AI-driven drug-discovery workflows and even AI-enabled sales. Proponents say AI can streamline early discovery by sifting through vast molecule libraries, potentially boosting hit rates before costly trials-but AI won't shorten clinical timelines or guarantee approvals. The stock trades at a premium valuation, even as the AI megatrend reshapes pharma. Investors should weigh the growth upside against the multiple and consider whether Veeva's scope in data, compliance, and subscriptions justifies the price today.
  • Big Banks Lean Into Quantum Computing Stocks: Should Investors Follow?
    October 16, 2025, 9:51 AM EDT. Institutional money is flowing into quantum computing, with IonQ raising about $2 billion in equity at a premium, underwritten by JPMorgan Chase and tied to Susquehanna's Heights Capital. IonQ is selling about 16.5 million shares at $93 each-roughly a 20% premium-a move that extends its cash runway. JPMorgan is also advancing a broader $1.5 trillion tech investment plan with quantum computing named among the targeted areas in security and resiliency. Meanwhile, giants like Alphabet, Microsoft, and IBM offer lower-risk quantum exposure than pure-play names like Rigetti or IonQ themselves. The big question: does bank-backed funding alter the risk/reward calculus for quantum stocks, or should investors stay cautious?
  • Cameco Corporation Stock Analysis & Forecast: Uranium Upcycle, Fundamentals, and Technical Breakout
    October 16, 2025, 9:50 AM EDT. Cameco Corporation sits at the center of the global uranium supply chain as a top producer with Canadian mines like Cigar Lake and McArthur River, plus a 49% stake in Westinghouse Electric Company. The company posted a surge in fundamentals, with adjusted quarterly EPS of US$0.71 (up ~373% YoY) and revenue up ~47%, underpinned by higher realized uranium prices and long-term contracts. Analysts expect earnings growth above 120% in 2025 and beyond. A healthy balance sheet, moderate leverage, and capacity rebuilds support upside as demand tightens in the upcycle for nuclear power. Technically, the stock recently broke above resistance in an ascending base, with a rising RS line and inclusion in growth lists like IBD 50.
  • BigBear.ai Up 68% in a Month: Should You Buy BBAI Stock Now?
    October 16, 2025, 9:49 AM EDT. BigBear.ai has jumped 68% in the last month as announced partnerships boost investor confidence, even after disappointing quarterly results. In Q2, revenue declined 18% year over year and adjusted EBITDA was -$8.5 million, widening losses from the prior year. Management cut its full-year revenue guidance to a midpoint of $125-$140 million, down from $170 million, signaling a weaker demand backdrop. Bulls point to recent wins-the Nashville International Airport deployment of its AI-powered facial recognition, a U.S. Navy maritime exercise, and a ground-operations edge AI partnership-as evidence the company is gaining traction in defense and security markets. Valuation looks stretched at about 15.5x forward sales, raising questions about sustainability unless contract momentum and margin improvement materialize.
  • AGNC Investment vs. EPR Properties: Which Dividend REIT Is Better for Sustainable Income?
    October 16, 2025, 9:48 AM EDT. AGNC Investment (AGNC) delivers a very high yield (~14.5%) with a monthly dividend of $0.12, powered by leverage on Agency mortgage-backed securities (MBS). Management cites ROE in the 18-20% range, but rising financing costs or muted spreads could force a payout reset. EPR Properties (EPR) offers a more modest yield (~6.5%) and a long-running monthly dividend supported by cash flows from its experiential real estate portfolio (theaters, attractions, fitness centers). EPR has raised its payout in recent years, though it remains exposed to real estate cycles. For income seekers, AGNC trades higher risk for yield; EPR emphasizes steadier cash flow and gradual growth. The choice hinges on risk tolerance, leverage comfort, and diversification within REITs.
Go toTop